Ocugen, Inc., based in Pennsylvania, USA is a biotechnology company specializing in gene and cell therapies, biologics, and vaccines, has announced that its chairman, CEO, and co-founder, Shankar Musunuri, and chief scientific officer, head of research, development and medical, Arun Upadhyay, will be presenting at the American Association of Physicians of Indian Origin (AAPI) Convention and Scientific Assembly this year.

Dr Upadhyay will present in the product theatre session titled “Emerging Cell and Gene Therapy Technologies: Novel curative approaches to breaking barriers in disease management” while Dr Musunuri will present during the CEO Leaders Forum on the subject “Shaping Healthcare for the Future,” according to a release.

“The AAPI is an impressive organization that fosters the continued leadership of healthcare professionals of Indian origin through educational and networking opportunities, while also supporting the next generation of leaders and giving back to people in need through its charitable foundation,” said Dr Musunuri. “We look forward to interacting with top physicians, health professionals, academicians, and scientists from across the country to drive positive change throughout our dynamic healthcare environment.”

“It’s an honour to share more about Ocugen’s scientific platforms, especially modifier gene therapy, with this important audience,” said Dr Upadhyay. “Opportunities like this for an open dialogue among industry and practitioners is critical to advancing treatment options and providing access for patients.”

Dedicated to making a positive difference in the lives of patients by pursuing innovative approaches and exploring new scientific frontiers, Ocugen leverages its exceptional intellectual and human resources to drive meaningful advancements in healthcare.